WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Saturday, August 18, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email


Artificial Blood and Plasma: Global Markets to 2027
Wednesday, June 13, 2018

LONDON, June 13, 2018 /PRNewswire/ -- Report Scope:
The report provides a detailed overview of the global market for artificial blood, focusing on various important aspects of the market, such as research and development, clinical trial outcomes, approval status and the potential commercial market for artificial blood products.The report includes a discussion of artificial oxygen carrier products manufacturing, product features, technology and methodology used, available results of laboratory and clinical tests, product effectiveness, and factors that are affecting the market.

Download the full report: https://www.reportbuyer.com/product/5370220

Further, it explains the major drivers and regional dynamics of the global artificial blood market and current trends within the industry.

The report concludes with a special look at the potential artificial blood products that may enter the blood market postapproval from international authorities.Detailed profiles of the key players in the global artificial blood market and the current development stages of their products have been included.

Excluded from consideration are product physical and chemical properties, detailed and unpublished clinical/lab results on the products, and detailed methodology/techniques used for product production.

Report Includes:
- 144 tables
- An overview of global market for artificial blood plasma
- Analyses of global market trends, with projections of compound annual growth rates (CAGRs) through 2027
- Identification of growth-driving factors influencing the artificial blood plasma market, as well as opportunities, restraints, and technological developments
- Profiles of leading companies in the market, including Alliance Pharmaceutical Corp., Baxter Healthcare Corp., Northfield Laboratories Inc., Sanguine Biosciences, and Therapure Biopharma Inc.

Summary
The human body contains a vital fluid called blood, which delivers oxygen and nutrients to the body cells and carries waste products away from the cells in a gas exchange process.The artificial bloods being developed are intended to satisfy some of the functions of biological blood, particularly in humans.

The objective of first-generation oxygen-carrying blood substitutes is solely to imitate blood's oxygen transport function. Intense research is going on with more functional artificial blood, which could hypothetically emulate additional components and functions of human blood. Currently, two
fundamental approaches to artificial blood are being taken: perfluorocarbons and hemoglobin-based oxygen carriers. These artificial blood products could increase survival of patients, especially during surgery when blood loss is high.

Blood shortages and the lack of appropriate substitutes have resulted in numerous preventable deaths. In the future, blood shortfalls may be even more severe, as current shortage projections do not take into account the more intense need for blood in cases of mass civilian casualties, such as common calamities, terrorist assaults and wars.

Report Scope:
The report provides a detailed overview of the global market for artificial blood, focusing on various important aspects of the market, such as research and development, clinical trial outcomes, approval status and the potential commercial market for artificial blood products.The report includes a discussion of artificial oxygen carrier products manufacturing, product features, technology and methodology used, available results of laboratory and clinical tests, product effectiveness, and factors that are affecting the market.

Further, it explains the major drivers and regional dynamics of the global artificial blood market and current trends within the industry.

The report concludes with a special look at the potential artificial blood products that may enter the blood market postapproval from international authorities.Detailed profiles of the key players in the global artificial blood market and the current development stages of their products have been included.

Excluded from consideration are product physical and chemical properties, detailed and unpublished clinical/lab results on the products, and detailed methodology/techniques used for product production.

Report Includes:
- 144 tables
- An overview of global market for artificial blood plasma
- Analyses of global market trends, with projections of compound annual growth rates (CAGRs) through 2027
- Identification of growth-driving factors influencing the artificial blood plasma market, as well as opportunities, restraints, and technological developments
- Profiles of leading companies in the market, including Alliance Pharmaceutical Corp., Baxter Healthcare Corp., Northfield Laboratories Inc., Sanguine Biosciences, and Therapure Biopharma Inc.

Download the full report: https://www.reportbuyer.com/product/5370220

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/artificial-blood-and-plasma-global-markets-to-2027-300665624.html

SOURCE ReportBuyer



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Author Outlines Christian Management Style that Builds "People-Power" | Aug 18, 2018
Nav Respiratory Tract Infections Drug Development Pipeline Review 2018 Featuring Beijing Minhai Biotechnology, Sanofi and GlaxoSmithKline | Aug 17, 2018
Nav NightPro Announces Landmark Partnership with Omnivore | Aug 17, 2018
Nav Shepherd Expands and Welcomes Home Members of the Flock | Aug 17, 2018
Nav Global Breast Cancer Pipeline 2018 - Highly Active Deals Landscape with Numerous Investment Opportunities | Aug 17, 2018
Nav China Offshore Wind Power Markets Report 2018-2020 - Large-scale Central Government-owned Power Enterprises Dominate the Development of Offshore Wind Power | Aug 17, 2018
Nav Digital Agency Barrel Launches New E-commerce Flagship Website for MOSCOT | Aug 17, 2018
Nav OP Live Dallas to Feature Largest Collegiate Overwatch Tournament in North Texas Powered by Team Envy and the Dallas Fuel | Aug 17, 2018
Nav Global Digital Radiography Strategic Business Report 2016-2018 to 2024 - DR Installations Gain Momentum Worldwide | Aug 17, 2018
Nav 2018 Mucopolysaccharidosis Disorders Drug Development Pipeline Review | Aug 17, 2018
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News